Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : CAR-T Cell Therapy
Therapeutic Area : Oncology
Study Phase : Discovery
Sponsor : Ginkgo Bioworks
Deal Size : Undisclosed
Deal Type : Acquisition
Ginkgo Bioworks Acquires Modulus Cell Therapy Platform Assets
Details : Through the acquisition, Ginkgo will get access to the Modulus cell therapy platform assets, including their chimeric antigen receptor and switch receptor libraries for solid tumors, autoimmune, etc.
Brand Name : Undisclosed
Molecule Type : Cell and Gene therapy
Upfront Cash : Undisclosed
April 02, 2024
Lead Product(s) : CAR-T Cell Therapy
Therapeutic Area : Oncology
Highest Development Status : Discovery
Sponsor : Ginkgo Bioworks
Deal Size : Undisclosed
Deal Type : Acquisition
LOOKING FOR A SUPPLIER?